These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16601711)

  • 1. Trends in biotech literature 2005.
    Lawrence S
    Nat Biotechnol; 2006 Apr; 24(4):380. PubMed ID: 16601711
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in biotech literature 2007.
    Taroncher-Oldenburg G; Marshall A
    Nat Biotechnol; 2008 Oct; 26(10):1062. PubMed ID: 18846063
    [No Abstract]   [Full Text] [Related]  

  • 3. Decoding the literature on genetic variation.
    Coronini R; de Looze MA; Puget P; Bley G; Ramani SV
    Nat Biotechnol; 2003 Jan; 21(1):21-9. PubMed ID: 12511903
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in biotech literature 2009-2010.
    Peng W
    Nat Biotechnol; 2011 Sep; 29(9):781. PubMed ID: 21904313
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in biotech literature 2006.
    Taroncher-Oldenburg G; Marshall A
    Nat Biotechnol; 2007 Sep; 25(9):961. PubMed ID: 17846614
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech financing retrenches in Q2.
    Lawrence S
    Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech patents still strong.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1341. PubMed ID: 18066014
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights into US public biotech sector using patenting trends.
    Aggarwal S; Gupta V; Bagchi-Sen S
    Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: the impact of biotech.
    Janssens B; Schaefer U
    Biotechnol J; 2010 Jan; 5(1):3. PubMed ID: 20069583
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech patenting matures.
    Lawrence S
    Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech slumps in Q1.
    Lawrence S
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract]   [Full Text] [Related]  

  • 13. 2005: biotech partners up.
    Lawrence S
    Nat Biotechnol; 2006 Feb; 24(2):126. PubMed ID: 16465145
    [No Abstract]   [Full Text] [Related]  

  • 14. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the biotech literature.
    Lawrence S
    Nat Biotechnol; 2005 Apr; 23(4):408. PubMed ID: 15815656
    [No Abstract]   [Full Text] [Related]  

  • 16. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 17. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 18. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 20. Who'd be a referee?
    Nat Nanotechnol; 2008 Mar; 3(3):119. PubMed ID: 18654473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.